RecruitingNot ApplicableNCT07684885

NIBP Study for Neonate and Pediatric Subject Populations

Non-Invasive Blood Pressure Accuracy Study for Neonate and Pediatric Subject Populations


Sponsor

GE Healthcare

Enrollment

110 participants

Start Date

May 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is developing new NIBP enhancement and test it in clinical environment with neonates and children population subjects.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called NIBP Measurement for people with blood pressure and blood pressure measurement. The study is currently recruiting participants at 2 locations. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENIBP Measurement

The collection of non-invasive blood pressure measurements using NIBP Standard Parameter Module with SuperSTAT algorithm with simultaneous invasive blood pressure waveform recordings per discretion of the sponsor upon combining the data from other clinical studies to comply with ISO 81060-2:2018 +AMD2:2024.


Locations(2)

Helsinki University Hospital

Helsinki, Finland

Helsinki University Hospital

Helsinki, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07684885


Related Trials